Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2847352

C=C(C)C(=O)OCCN(CC)CC.Cl

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA known ✓ P21397 1/20 0.42
HTR3A known ✓ P46098 1/20 0.42
HRH3 known ✓ Q9Y5N1 1/20 0.42
SCN1A known ✓ P35498 1/20 0.41
SCN2A known ✓ Q99250 1/20 0.41
SCN3A known ✓ Q9NY46 1/20 0.41
CHRM2 known ✓ P08172 1/20 0.41
CHRM4 known ✓ P08173 1/20 0.41
CHRM5 known ✓ P08912 1/20 0.41
CHRM1 known ✓ P11229 1/20 0.41
CHRM3 known ✓ P20309 1/20 0.41
THRB P10828 1/20 0.53
TSHR P16473 5/20 0.52
NPSR1 Q6W5P4 2/20 0.45
CYP3A4 P08684 2/20 0.45
BLM P54132 1/20 0.45
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28273630 0.98 THRB (0.55) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL14874 0.98 THRB (0.55) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL22684899 0.96 THRB (0.53) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL9800939 0.96 THRB (0.53) THRBTSHRNPSR1CYP3A4BLM
Chloromethane SCHEMBL1128072 0.94 THRB (0.52) THRBTSHRNPSR1CYP3A4BLM
Acetic Acid SCHEMBL10336380 0.94 THRB (0.52) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL10697522 0.94 THRB (0.55) THRBTSHRNPSR1CYP3A4BLM
Boric Acid SCHEMBL8763859 0.93 THRB (0.50) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL10598725 0.93 THRB (0.55) THRBTSHRNPSR1CYP3A4BLM
SCHEMBL28477901 0.93 THRB (0.50) THRBTSHRNPSR1CYP3A4BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154401-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2025-05-15 US claimed
US-12209218-B2 Reduced-polymer-loading, high-temperature fracturing fluids and methods and systems related thereto SAUDI ARABIAN OIL COMPANY (SA) 2025-01-28 US claimed
US-20240425748-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2024-12-26 US claimed
WO-2024263632-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2024-12-26 WO claimed
CN-115926663-A Photo-thermal dual-debonding adhesive and preparation method thereof 上海固柯胶带科技有限公司 2023-04-07 CN claimed
US-9119849-B2 Substituted guar protein extracts and production/applications thereof RHODIA CHIMIE (FR) 2015-09-01 US claimed
US-20100093933-A1 Substituted Guar Protein Extracts and Production/Applications Thereof RHODIA CHIMIE (FR) 2010-04-15 US claimed
US-20250154401-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2025-05-15 US disclosed
US-12209218-B2 Reduced-polymer-loading, high-temperature fracturing fluids and methods and systems related thereto SAUDI ARABIAN OIL COMPANY (SA) 2025-01-28 US disclosed
US-20240425748-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2024-12-26 US disclosed
WO-2024263632-A1 REDUCED-POLYMER-LOADING, HIGH-TEMPERATURE FRACTURING FLUIDS AND METHODS AND SYSTEMS RELATED THERETO SAUDI ARABIAN OIL COMPANY (SA) 2024-12-26 WO disclosed
US-20160235645-A1 GUAR PROTEIN EXTRACTS AND COMPOSITIONS COMPRISED THEREOF AS SURFACE TREATING AND/OR MODIFYING AGENTS RHODIA CHIMIE (FR) 2016-08-18 US disclosed
US-9119849-B2 Substituted guar protein extracts and production/applications thereof RHODIA CHIMIE (FR) 2015-09-01 US disclosed
US-4981936-A CATIONIC FLOCCULANTS POLYPURE, INC. (US) 1991-01-01 US disclosed
EP-0383358-A2 Light-sensitive material containing silver halide reducing agent and polymerizable compound FUJI PHOTO FILM CO., LTD. (JP) 1990-08-22 EP disclosed
US-4767017-A EPOXY RESIN MATRIX REINFORCED WITH POLYAMIDE FILAMENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-08-30 US disclosed
US-4678821-A ARAMID FIBER COATED WITH ADHESION MODIFIER IN POLYMER MATRIX E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-07-07 US disclosed
US-4618554-A AN AMINOALKYL (METH)ACRYLATE TOYO INK MFG. CO., LTD. (JP) 1986-10-21 US disclosed
US-4480025-A Water reservoir layers in bleach-fix sheets EASTMAN KODAK COMPANY (US) 1984-10-30 US disclosed
EP-0117165-A2 Bleach-fix sheet EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093933-A1 Substituted Guar Protein Extracts and Production/Applications Thereof CUTA, HIRA, PMP22 MAOA 2683/4885HTR3A 4411/4885HRH3 1325/4885
US-20160235645-A1 GUAR PROTEIN EXTRACTS AND COMPOSITIONS COMPRISED THEREOF AS SURFACE TREATING AND/OR MODIFYING AGENTS CUTA, GLA, PAG1 MAOA 1719/4885HTR3A 4253/4885HRH3 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.